This protocol uses a hormone produced in the gut to help regulate: Blood sugar and insulin levels Digestive processes Metabolic stability for long-term wellness Using lower doses aims to enhance safety, reduce adverse effects, and promote sustained improvements in overall health
After 4 weeks, dose increases occur every 24 weeks based on your tolerability and weight loss response, not on a rigid calendar
Originally developed in Australia in the 1990s, it was designed to harness the fat-burning properties of growth hormone without triggering its broader hormonal effects
Combined with extensive clinical evidence and growing real-world use, these factors have driven widespread physician preference and patient adoption
(Midi does not prescribe this or other unapproved peptides.) What the science says: The majority of research on Epitalon is from animal studies and small human observational studies, not large, randomized controlled trials